Author(s): Roche PW, Triccas JA, Winter N
Abstract Share this page
Abstract Three billion doses of the bacille Calmette-Guérin (BCG) vaccine have been given over the past 60 years. BCG has a widely variable ability to protect humans against tuberculosis. This article examines some of the reasons for this variability, and discusses ways in which BCG vaccination might be improved.
This article was published in Trends Microbiol
and referenced in Journal of Microbial & Biochemical Technology